Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.
about
In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3.Sustained expression of insulin by a genetically engineered sertoli cell line after allotransplantation in diabetic BALB/c miceTransfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular diseaseHigh-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets.Lentivirus vector-mediated gene transduction of CNGRC peptide in rat adipose stem cellsRegional gene therapy to enhance bone repair.Human cancer gene therapy with cytokine gene-modified cells.Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cellsGene therapy of gynaecological diseases.In vivo gene delivery with L-tyrosine polyphosphate nanoparticles.Viral vectors for vascular gene therapyPoly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination.De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications.Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectorsPseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E.Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer.Creation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1.Development of an Ad7 cosmid system and generation of an Ad7deltaE1deltaE3HIV(MN) env/rev recombinant virus.Adenoviral vector-mediated overexpression of osteoprotegerin accelerates osteointegration of titanium implants in ovariectomized rats.Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastomaGene transfer mediated by different viral vectors following direct cannulation of mouse submandibular salivary glands.T Helper 17 Promotes Induction of Antigen-Specific Gut-Mucosal Cytotoxic T Lymphocytes following Adenovirus Vector Vaccination.Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats.Insight into antibody responses induced by plasmid or adenoviral vectors encoding thyroid peroxidase, a major thyroid autoantigen.Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA.Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.Cotransfection of heme oxygenase-1 prevents the acute inflammation elicited by a second adenovirus.Intramarrow bone morphogenetic protein 4 gene delivery improves local bone quality in femurs of ovariectomized rabbits.Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies.In vivo transduction of thymic dendritic cells with adenovirus and its potential use in acute inflammatory diseases.Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector.Adenoviral-mediated transfer of tissue plasminogen activator gene into brain capillary endothelial cells in vitro.Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo.Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death.Sertoli Cells Engineered to Express Insulin to Lower Blood Glucose in Diabetic Mice
P2860
Q33782356-3089F422-A870-460D-B733-E2D8704C6893Q33819873-D4A4FE5B-568B-4A75-9D81-67CD2564AC9AQ33826170-5A85F3E2-6116-4818-8411-65ECD912553FQ33851759-CA5BB3C7-B06F-41C8-AF52-FF829D1BF081Q34218552-D6040A39-FD89-483C-AD28-04C217817CD2Q34731216-CFD2C42A-AD37-482E-8C49-BCE10BDB1AF1Q35110929-5673D4DE-8A17-4307-A645-434A191C7E2AQ35629594-628ABE89-64AD-4B6E-A3D7-4020DB0EC491Q35907018-221017C4-B5D6-4A64-B226-45F3260D8A35Q36694952-4F32A2DC-760B-47A1-9CFF-688A2876801FQ36922247-00E7171C-F45A-41F6-8036-36E53A24A3DCQ37128807-0EDEFCFD-9766-4C69-8357-2C2154A5474DQ37569631-067D54BB-5A76-4706-AD2E-EE587CC01678Q37805248-0B6606A1-E82A-4301-BAF8-9DF1DF350A60Q38321960-D3FAB6B1-5E34-4A30-9E39-4DD77250A945Q39502394-18B78262-AC06-4D79-BB97-606EF3617721Q39601057-81D5E155-1C44-4745-9E86-85ED53EFE1B2Q39926337-B771BBEF-E8B0-4C47-9579-5D44E52FDC27Q40625018-58C59D82-06B2-44A8-8A07-875A0882DC71Q40669254-6A8EC0BA-B18C-4B7D-A86C-B069C2F0DADCQ42148836-9104874D-1310-4F95-B230-4E7B2593C330Q42412771-13AEA7D2-AB5E-4368-8843-9966699BEAD7Q44065907-E48DFAA5-FC3F-4510-A0B9-5C7EA5D5D08BQ44133482-D88CD449-875D-4A27-8B6B-8C2AF60FD455Q44211017-9A373005-0997-4646-BE7E-4CD0EE399C51Q44391669-4443C7B6-D461-448C-81B1-0F65FD5A8797Q45859390-7FE05AA6-186E-459D-9806-62339DCCB694Q45862335-6AAB09F1-3F47-4E6E-8941-36A05F551379Q45864746-FAE3F7CB-C3AD-4C7D-BD69-76D46FF63ABFQ45865133-CEEF4FA2-3651-4050-9A0D-D5B34518C7C0Q45871871-12F3229A-B6D7-4044-BE5F-2A1EDA15ED86Q45879455-AC84408E-7CEA-4C3D-9438-4DEA1213A896Q45883079-5F30552A-25A8-4E81-82C2-D0533234CF01Q45885438-EB0E3FF2-74E7-4AB0-947B-4CDA62A28F7EQ46070218-EDA6EBDB-5ADF-4FFB-8EEC-577B8DFA2C34Q51191793-8668D44E-BB0D-42FE-96A5-83CB6AF7B020Q51728843-A0272FF0-95D6-4C14-9047-200689980740Q58806285-B8789C16-5342-48E0-92F2-3E33510631E7
P2860
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.
@en
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.
@nl
type
label
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.
@en
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.
@nl
prefLabel
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.
@en
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.
@nl
P2093
P1433
P1476
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.
@en
P2093
Dieterlé A
Pavirani A
Stoeckel F
P356
10.1016/S0165-2478(97)00049-7
P577
1997-06-01T00:00:00Z